Skip to main content

linagliptin

Generic: LINAGLIPTIN·Brand: Glyxambi, Jentadueto, LINAGLIPTIN, TRADJENTA, Tradjenta, Trijardy

linagliptin: 2 clinical trials tracked.

linagliptin evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about linagliptin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Mild Cognitive Impairment

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trials (2)

Effects of Liraglutide, Empagliflozin and Linagliptin on Mild Cognitive Impairment Remission in Type 2 Diabetes (LIGHT-MCI): A Multicentre, Randomised Controlled Trial With An Extension Phase

NCT05313529·N/A
Active, not recruiting

Primary endpoint: Mild cognitive impairment (MCI) remission rate

InterventionalRandomizedopen396 targetStarted 2022-10Completion 2026-075 sites · ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

NCT03281369·Phase 1/Phase 2
Terminated

Primary endpoint: Stage 1: Percentage of Participants With Objective Response (OR), as Determined by Investigator According to RECIST v1.1

InterventionalRandomizedopen219 enrolledStarted 2017-10Completion 2025-1028 sites · Australia, Israel, South Korea, Spain…Hoffmann-La Roche